Causes of Death in Long-Term Nasopharyngeal Carcinoma Survivors
Nasopharyngeal Carcinoma
Heart Diseases
nasopharyngeal carcinoma
survivors
Nasopharyngeal Neoplasms
3. Good health
SEER
cause of death
03 medical and health sciences
0302 clinical medicine
Cause of Death
Humans
Public Health
Survivors
Public aspects of medicine
RA1-1270
long-term survival
DOI:
10.3389/fpubh.2022.912843
Publication Date:
2022-07-07T07:36:39Z
AUTHORS (6)
ABSTRACT
PurposeTo assess the causes of death (COD) and long-term survival after nasopharyngeal carcinoma (NPC) diagnosis.MethodsUsing linked data from the Surveillance, Epidemiology, and End Results program, patients with NPC diagnosed from 1990 to 2010 and followed up >5 years were identified. Chi-squared test, the Kaplan–Meier method, and the Cox proportional hazard model were used for analyses.ResultsAmong the 3,036 long-term NPC survivors, 1,432 survived for >5–10 years and 1,604 survived for >10 years. The most common COD was primary NPC (36.9%), followed by other causes (28.7%), other cancers (15.3%), cardiac disease (12.9%), and non-malignant pulmonary disease (6.2%). With a median follow-up of 125 months, deaths from NPC decreased with increasing time from diagnosis, while death because of cardiac disease and other causes increased. In those aged <50 years, death due to NPC remained the main COD over time, while cardiopulmonary disease-related death was the leading COD in patients aged ≥50 years. In White patients, death due to NPC decreased, and death due to cardiac disease increased over time. Death from NPC remained significant in Black and Asian patients even 15 years after the diagnosis of NPC, while death due to cardiac disease significantly increased after 9 years of diagnosis in Black patients. Multivariate analyses showed that the independent factors associated with inferior NPC-specific survival were older age, Asians, American Indian/Alaska Native, regional stage, distant stage, and diagnosis in the early years.ConclusionsThe probability of death from primary NPC remains significant even 15 years after the NPC diagnosis. Our study advocates continued surveillance for NPC survivors beyond the traditional 5 years. Individualized follow-up strategies are required for patients with NPC of different ages and races.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....